RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL
Clinical trial NCT05425654 · UNKNOWN
Trial details
- NCT number
- NCT05425654
- Sponsor
- National Research Center for Hematology, Russia
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-17
- Primary completion
- 2023-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.